• DMXAA (Vadimezan): Advanced Protocols for Tumor Immunity Res

  2026-06-10

  DMXAA (Vadimezan) is at the forefront of cancer biology research, serving as a potent apoptosis inducer and anti-angiogenic agent with unique utility in both in vitro and in vivo models. This article delivers a practical, evidence-backed guide for maximizing experimental success, highlighting new synergy with nuclear-targeted delivery platforms to amplify innate anti-tumor immunity.

• Synergistic Antitumor Immunity via Radiotherapy and Dual Che

  2026-06-09

  This study demonstrates that combining radiotherapy with PD-1 and TIGIT immune checkpoint blockade synergistically induces robust abscopal tumor regression and durable immune memory, mediated by CD8+ T cells and M1 macrophage polarization. The findings provide a mechanistic framework for overcoming resistance to PD-1 monotherapy and optimizing combination immunotherapies in cancer.

• Anti-Inflammatory, Anti-Angiogenic Airway Stents Suppress Re

  2026-06-09

  This study introduces a dual-action airway stent with both anti-inflammatory and anti-angiogenic properties to address tracheal in-stent restenosis (TISR), a major limitation of current stent technologies. The stent's combined delivery of anlotinib and silver nanoparticles significantly reduced vascularization, inflammation, and fibroblast activation in vivo, offering a promising strategy for improved airway stent durability.

• Smoothened Agonist (SAG): Precision Activation of the Hedgeh

  2026-06-08

  Smoothened Agonist (SAG) empowers researchers with robust, selective Hedgehog pathway activation across disease modeling, stem cell, and neuroregeneration workflows. This article distills advanced protocol strategies, troubleshooting tips, and cutting-edge insights from recent tumorigenesis studies to maximize experimental reliability and translational impact.

• Nanoparticle Uptake Mechanisms in Human Corneal Epithelial C

  2026-06-08

  This study elucidates how nanoparticle size and surface chemistry influence cellular uptake by human corneal epithelial cells, identifying macropinocytosis and caveolae-mediated endocytosis as dominant internalization routes. The findings inform the rational design of advanced ocular drug-delivery systems with improved bioavailability and therapeutic precision.

• Spiroplasma eriocheiris Entry to Drosophila S2 Cells via End

  2026-06-07

  This study reveals that Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells through clathrin-mediated endocytosis and macropinocytosis, not caveolae-dependent pathways. These findings define the cellular entry mechanisms of S. eriocheiris, advancing invertebrate pathogen-host modeling and highlighting cytoskeletal contributions to infection.

• Ceftolozane Sulfate: Optimizing PK/PD Studies and Resistance

  2026-06-06

  Ceftolozane sulfate stands out for robust, stable bactericidal activity against multidrug-resistant Pseudomonas aeruginosa and Enterobacterales, enabling precise PK/PD-driven experimental design. This article delivers actionable in vitro and in vivo workflow guidance, advanced troubleshooting, and protocol upgrades grounded in the latest reference evidence.

• Practical Use of TBST (Tris-Buffered Saline and Tween 20) in

  2026-06-05

  TBST (Tris-Buffered Saline and Tween 20) addresses high background and nonspecific binding in immunoassays by providing a reliable blocking and washing buffer. It is best suited for workflows such as Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry, but should be avoided in assays sensitive to non-ionic detergents.

• Jasplakinolide: Redefining Actin Cytoskeleton Research Tools

  2026-06-05

  Explore how Jasplakinolide, a potent actin polymerization inducer, is transforming cytoskeletal research. This article uniquely bridges molecular mechanism, assay design, and translational insights for advanced experimental workflows.

• AM251: Precision CB1 Receptor Antagonist for Neuroscience Re

  2026-06-04

  AM251 empowers researchers to dissect CB1 receptor signaling with nanomolar precision, enabling rigorous exploration of endocannabinoid modulation in neuropharmacology and metabolic studies. This guide distills best practices, experimental workflows, and troubleshooting strategies, leveraging APExBIO’s reagent quality for reproducible cannabinoid receptor research.

• Baicalin Reactivates Adult Visual Cortex Plasticity in Ambly

  2026-06-04

  This study demonstrates that baicalin reactivates ocular dominance plasticity and restores visual acuity in adult mice with amblyopia—a condition previously considered refractory to pharmacological intervention in adulthood. The findings suggest a mechanistic pathway involving reduced cortical inhibition, positioning baicalin as a promising candidate for translational research in neuroplasticity and vision restoration.

• Stress Fiber Anisotropy Regulates Force-Dependent Gene Expre

  2026-06-03

  Wei et al. (2020) reveal that the orientation and organization of actin stress fibers determine how living cells transduce different applied force modes into chromatin stretching and gene upregulation. Their work integrates advanced 3D magnetic twisting cytometry and modeling to clarify the mechanical basis for force-mode–dependent gene expression, with broad implications for cytoskeletal dynamics research.

• Bestatin Dissects Jasmonate Signaling Pathways in Arabidopsi

  2026-06-03

  The reference study reveals how bestatin, an aminopeptidase inhibitor, serves as a chemical genetics tool to unravel jasmonate signaling mechanisms in Arabidopsis. By generating and analyzing bestatin-resistant mutants, the authors identify novel genetic loci involved in jasmonate-mediated plant defense and development.

• TCAIM Regulates Mitochondrial Metabolism via OGDH Degradatio

  2026-06-02

  Wang et al. reveal that the mitochondrial DNAJC co-chaperone TCAIM specifically binds to and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, thereby modulating mitochondrial metabolism. This discovery elucidates a previously unrecognized post-translational regulatory mechanism for the TCA cycle, with implications for metabolic pathway research and disease modeling.

• Quercetin as a PI3K Inhibitor: Innovations in Cancer and Fer

  2026-06-02

  Explore how Quercetin, a potent PI3K inhibitor, advances cancer research and ferroptosis-focused therapies. This article delivers unique mechanistic insights and practical assay guidance based on the latest scientific evidence.

687 records 10/46 page Previous Next First page 上5页 678910 下5页 Last page